Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Swiss-pharmaceutical giant, Novartis, announced Thursday that it plans to build a $1.1 billion research hub in San Diego as ...

Eli Lilly (LLY) stock in focus as the company projects earnings headwinds from IPR&D charges estimated at $1.57B for Q1 2025.

It’s unclear whether tariffs will influence more companies to make more drugs in the U.S. like President Donald Trump is ...

OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open ...

Eli Lilly's (LLY) cease-and-desist letter is dismissed by weight loss drug compounder, OrderlyMeds. Read more here.

In a report released on April 9, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and ...

Shares in Swiss drugmaker Novartis (NVS) were looking perkier today as it set out plans to invest $23 billion in U.S. manufacturing to beat the ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Lina Manufacturing Limited, the pharmaceutical manufacturing arm of Sunshine Holdings PLC, unveiled its new brand identity – a powerful logo that reflects the company’s evolution, vision, and ...

Invisors, a Workday services provider, has officially been named as one of the UK's Best Workplacestm 2025 by Great Place To Work®, the global authority on workplace culture, ranking 47 in the Small ...

Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends in the pharmaceutical sector.